✦ LIBER ✦

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia

✍ Scribed by Lin, T S; Flinn, I W; Lucas, M S; Porcu, P; Sickler, J; Moran, M E; Lucas, D M; Heerema, N A; Grever, M R; Byrd, J C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alemtuzumab (Campath-1H) in the treatmen

✍ Alinari, L; Lapalombella, R; Andritsos, L; Baiocchi, R A; Lin, T S; Byrd, J C 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 146 KB

Clinical effects of alemtuzumab (Campath

✍ Anders Osterborg; Hakan Mellstedt; Michael Keating 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 124 KB

Campath-1H in Patients with Chronic Lymp

📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Alemtuzumab : A New Option for Refractor

✍ Judith A. Smith 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB

Treatment of refractory chronic lymphocy

✍ Ulrike Heider; Claudia Fleissner; Ivana Zavrski; Christian Jakob; Toralf Dietzel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

5.24 Pentostatin, Alemtuzumab, and Low-D

✍ Clive S. Zent; Betsy R. LaPlant; Brian Link; Timothy G. Call; Tait D. Shanafelt; 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 87 KB